Table 2 AD case demographics and neuropathological characteristics for lipidomics

APOE2 carriers

2/3

93

F

3

2/3

92

F

6

2/3

92

F

3

2/3

90

F

2

2/3

91

F

5

2/3

96

M

5

2/3

67

M

6

2/3

94

M

3

Age ± SD (years)

89.38 ± 9.2

PMI (range; mean) hours

1.4-3.3; 2.48

APOE3/3

3/3

80

F

6

3/3

87

F

6

3/3

81

F

6

3/3

91

F

6

3/3

89

F

6

3/3

80

F

6

3/3

80

F

6

3/3

86

M

6

3/3

85

M

6

3/3

83

M

6

3/3

81

M

6

3/3

92

M

6

Age ± SD (years)

84.5 ± 4.4

PMI (range; mean) hours

2-9; 4.08

APOE4 carriers

3/4

83

F

6

3/4

80

F

6

3/4

89

F

6

3/4

88

F

6

3/4

84

F

6

3/4

89

F

6

3/4

90

F

6

3/4

87

F

6

3/4

88

M

6

3/4

79

M

6

3/4

76

M

6

3/4

82

M

6

3/4

84

M

6

3/4

91

M

6

3/4

80

M

6

3/4

79

M

6

4/4

79

F

6

4/4

80

F

6

4/4

82

M

6

4/4

82

M

6

4/4

84

M

6

4/4

84

M

6

Age ± SD (years)

83.6 ± 4.2

PMI (range; mean) hours

1-15; 4035